TIMP1 and fibrosarcoma: In vitro experiments on fibrosarcoma confirmed that intrathecal injection of the MMP inhibitor TIMP-1-GPI inhibited cell proliferation and migration, increased apoptosis, and enhanced sensitivity to chemotherapeutic agents (107).